Evidence map›Paper›PMID 22511615›Full record

ArticleArthritis care & research2012

Umbilical cord blood levels of maternal antibodies reactive with p200 and full-length Ro 52 in the assessment of risk for cardiac manifestations of neonatal lupus.

Joanne H Reed, Robert M Clancy, Kristen H Lee, Amit Saxena, Peter M Izmirly, Jill P Buyon

Registry-linked trialAbstract read
In one paragraph

Article in Arthritis care & research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00074373 (The Research Registry for Neonatal Lupus), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00074373 completednot on this map

The Research Registry for Neonatal Lupus

TypeobservationalSponsorNYU Langone HealthRan2010 to 2016Enrolled100ConditionsNeonatal Lupus, Systemic Lupus Erythematosus, Sjogren's Syndrome, Congenital Heart BlockArmsNo intervention, observational
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Article
  3. Variation in prenatal surveillance and management of anti-SSA/Ro autoantibody positive pregnancies.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Joanne H ReedNew York University School of Medicine, New York, USA. joanne.reed@nyumc.org
Robert M Clancy
Kristen H Lee
Amit Saxena
Peter M Izmirly
Jill P Buyon
New York University · US

Funding

Maternal Autoantibodies: Pathogenesis of Neonatal LupusR37AR042455 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BUYON, JILL P · 2008 to 2018
$4.0M
MATERNAL AUTOANTIBODIES--PATHOGENESIS OF NEONATAL LUPUSR01AR042455 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BUYON, JILL PAMELA · 1994 to 2007
$2.7M
RESEARCH REGISTRY FOR NEONATAL LUPUS-264942220N01AR042220 · NIAMS · HOSPITAL FOR JOINT DISEASES ORTHO INST · 1994 to 2003
$148k
NIAMS NIH HHS N01 AR042220NIAMS NIH HHS N01-AR-4-2271NIAMS NIH HHS R01 AR042455NIAMS NIH HHS R01-AR42455-16NIAMS NIH HHS R37 AR042455
6 · The paper itself

Abstract

objectiveMaternal anti-Ro autoantibodies are associated with cardiac manifestations of neonatal lupus (cardiac NL), yet only 2% of women with this reactivity have an affected child. Identification of a more specific marker would channel intense monitoring to fetuses at greater risk. This study aimed to determine whether autoantibodies against Ro 52 amino acids 200-239 (p200) confer added risk over autoantibodies to full-length Ro 52, Ro 60, or La.

methodsAnti-Ro-exposed pregnancies resulting in cardiac NL or no cardiac manifestations were identified from the Research Registry for Neonatal Lupus and the PR Interval and Dexamethasone Evaluation study. Umbilical cord (n = 123) and maternal (n = 115) samples were evaluated by enzyme-linked immunosorbent assay.

resultsThe frequencies of p200, Ro 52, Ro 60, and La autoantibodies were not significantly different between affected and unaffected children. However, neonatal anti-Ro 52 and Ro 60 titers were highest in cardiac NL and their unaffected siblings compared to unaffected neonates without a cardiac NL sibling. Although both maternal anti-Ro 52 and p200 autoantibodies were less than 50% specific for cardiac NL, anti-p200 was the least likely of the Ro autoantibodies to be false-positive in mothers who have never had an affected child. Titers of anti-Ro 52 and p200 did not differ during a cardiac NL or unaffected pregnancy from the same mother.

conclusionMaternal reactivity to p200 does not confer an added risk to fetal conduction defects over full-length Ro 52 or Ro 60 autoantibodies. Mothers who may never be at risk for having an affected child have lower anti-Ro 60 titers and may require less stringent echocardiographic monitoring compared to women with high-titer autoantibodies.

Indexed as

Immunodominant EpitopesAntibodies, AntinuclearBiomarkersEnzyme-Linked Immunosorbent AssayFemaleFetal BloodHeart BlockHumansLinear ModelsLupus Erythematosus, SystemicMalePeptide FragmentsPregnancyRegistriesRibonucleoproteinsRisk AssessmentAntibodies, AntinuclearBiomarkersImmunodominant EpitopesPeptide FragmentsRibonucleoproteinsSS-A antibodiesSS-A Antigen

Identifiers

PMID22511615
PMCPMC3413772
OpenAlexW2050375873

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.